Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26

Leukemia

Volumn 10, Issue 12, 1996, Pages 1891-1896

  Schnittger, S ^a,e   De Sauvage, F J ^b   Le Paslier, D ^c   Fonatsch, C ^a,d  

^a UNIVERSITY OF LÜBECK   (Germany)

^b GENENTECH INC   (United States)

^c FONDATION JEAN DAUSSET CEPH   (France)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

3q21q26 syndrome; Chromosomal localization; Dysmegakaryopoiesis; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3Q; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 3; CLINICAL ARTICLE; HUMAN; HUMAN CELL; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TELOMERE; THROMBOCYTOSIS; YEAST ARTIFICIAL CHROMOSOME;

EID: 0030465354     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Eaves AC, Eaves CJ. Erythropoiesis in culture. Clin Haematol 1984; 13: 371-391.
2. Prchal JF, Axelrad A. Bone marrow responses in polycythemia vera. New Engl J Med 1974; 290: 1382.
3. Depper JM, Leonara WJ, Kranke M, Waldmann TA, Greene WC. Augmented T cell growth factor receptor expression in HTLV-1 infected human leukemic T cells. J Immunol 1984; 133: 1691-1695.
4. Rambaldi A, Wakamiya N, Vellenga E, Horiguchi J, Warren MK, Kufe D, Griffin JD. Expression of the macrophage colony stimulating factor and c-frns genes in human acute myeloblastic leukemic cells. J Clin Invest 1988; 81: 1030-1035.
5. Mitjavila MT, leCouedic JP, Casadevall N, Navarro S, Vileval JL, Dubart A, Vainchenker W. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J Clin Invest 1991; 88: 789.
6. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Asham LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736-1744.
7. Bruno E, Briddel RA, Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation, Exp Hematol 1988; 16: 371-377.
8. Leary AG, Zeng HQ, Clarke SC, Ogawa M. Growth requirements for survival and entry into the cell cycle of primitive hemopoietic progenitors. Proc Natl Acad Sci USA 1992; 89: 4013-4017.
9. Mazur EM, Cohen JL, Bogard L, Mufson RA, Gesner TG, Yang YC, Clark SC. Recombinant gibbon interlukein-3 stimulates megakaryocyte colony growth in vitro from human peripheral blood progenitor cells. J Cell Physiol 1988; 136: 439-446.
10. Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatshuki F, Akimaya Y. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 1989; 74: 1241-1244.
11. Metcalf D, Hilton D, Nicola NA. Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood 1991; 77: 2150-2153.
12. Gordon MS, Hoffman R. Growth factors affecting human thrombo-cytopoiesis: potential agents for the treatment of thrombocytemia. Blood 1992; 80: 302-307.
13. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, Oles KJ, Huitgren B, Solberg LA, Goeddel DV, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
14. Bartley TD, Bogenberger J, Hunt P, Li Y, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covery T, Grouse H, Garcia A, Xu W, DelCastillo J, Biron J. Cole S, Hu CT, Pacifici R, Ponting I, Saris C, Wen D, Yung P, Lin H, Bosselman RA. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
15. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Holpel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Nlumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Balley MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Harra PJ, Hagen FS, Roth GJ, Foster DC. Cloning and expression of murine thrombopoietin and stimulation of platelel production in vivo. Nature 1994; 369: 568-571.
16. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M. Molecular cloning and characterization of hmpl, a new member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 1992; 89; 5640-5644.
17. Skoda RC, Seldin DC, Chiang M-K, Peichel CP, Vogt TF, Leder P. Murine c-mpl, a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J 1993; 12: 2645-2653.
18. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC, Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
19. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W. C-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369: 571-574.
20. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl deficient mice. Science 1994; 265: 1445-1447.
21. de Sauvage FJ, Carver-Moore K, Shiuh-Ming L, Ryan A, Dowd M, Eaton DL, Moore MW. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996; 183: 651-656.
22. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995; 86: 2494-2499.
23. Kaushansky K, Broudy VC, Grossmann A, Humes J, Lin N, Ren HP, Bailey MC, Papayannopoulou T, Forstrom JW, Sprugel KH. Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery following myelosuppressive therapy. J Clin Invest 1995; 96: 1683-1687.
24. Fibbe W, Heemskerk D, Laterveer L, Pruijt J, Foster D, Kaushansky K, Willemze R. Accelerated reconstitution of platelets and erythro-cytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995; 86: 3308-3313.
25. Alexander W, Roberts A, Nicola N, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl. Blood 1996; 87: 2162-2170.
26. Carver-Moore K, Hal E, Broxmeyer H, Luoh S-M, Cooper S, Peng J, Burstein S, Moore M, de Sauvage FJ. Low levels of erythroid and myeloid progenitors in TPO- and in c-mpl-deficient mice. Blood 1996 (in press).
27. Merthia N, Louache F, Vainchenker W, Wendling F. Oligodeoxy-nucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82: 1395-1401.
28. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, Malloy B, Hass P, Eaton D, Matthews W. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045-4052.
29. Vignon I, Dreyfus F, Melle J, Viguie F, Ribrag VLC, Soyri M, Gisselbrecht S. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993; 83: 877-883.
30. Sohma Y, Akahori H, Seki N, Hori T, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994; 353: 57-61.
31. Foster CD, Sprecher CA, Grant FJ, Kramer JM, Kuijper JL, Holly RD, Whitmore TE, Heipel MD, Bell A, Ching AFT, McGrane V, Hart C, O'Hara PJ, Lok S. Human thrombopoietin; gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 1994; 912: 13023-13027.
32. Gurney AL, Kuang W-J, Xie M-H, Malloy BE, Eaton DL, de Sauvage FJ. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 1995; 85: 981-988.
33. Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig WD, Thiel E, Freund M, Bodenstein H, Schwieder G, Grüneisen A, Aul C, Schnittger S, Rieder H, Haase D, Hild F. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). Leukemia 1994; 8: 1318-1326.
34. Horsman DE, Gascoyne RD, Barnett MJ. Acute leukemia with structural rearrangements of chromosome 3. Leuk Lymphoma 1995; 16: 369-377.
35. Seeker-Walker LM, Mehta A, Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group Study. Br J Haematol 1995; 91: 490-501.
36. Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentin MB, Ihle JN. Activation of the EVII gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome 3q26. Proc Natl Acad Sci USA 1992; 89: 3937-3941.
37. Levy ER, Parganas E, Morishita K, Fichelson S, James L, Oscier D, Gisselbrecht S, Ihle JN, Buckle VJ. DNA rearrangements proximal to the EVl1 locus associated with the 3q21q26 syndrome. Blood 1994; 83: 1348-1354.
38. Sambrook J, Frisch EF, Maniatis E. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Press: Cold Spring Harbor, NY, 1989.
39. Telenius H, Carter NP, Bebb CE, Nordenskjöld M, Ponder B, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992; 13: 718-725.
40. Emmons RVB, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR. Human thrombopoietin (TPO) levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068-4071.
41. Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, lani K, Asano S, Asou H, Kamada N, Yokota J, Morishita K, Ihle JN. Identification of a breakpoint cluster region 3′ of the ribophorin gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogeneous leukemia with inv(3)(q21q26). Blood 1994; 84: 2681-2688.
42. Bouscary D, Fontenay-Roupie M, Chretien S, Hardy AC, Viguié F, Picard F, Melle J, Dreyfus F. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome. Br J Haematol 1995; 91: 425-427.
43. Suzukawa K, Satoh H, Taniwaki M, Yokota J, Morishita K. The human thrombopoietin gene is located on chromosome 3q26.33-q27, but is not transcriptionally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome). Leukemia 1995; 9: 1328-1331.
44. Pinto MR, King MA, Goss CD, Bezwoda WR, Fernandes F, Mendelow B, McDonald TP, Dowdle E, Bernstein R. Acute megakaryoblastic leukemia with 3q inversion and elevated thrombopoietin (TSF): an autocrine role for TSF: Br J Haematol 1985; 61: 687-694.
45. Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86: 2516-2525.
46. Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricotz G. The 5q-anomaly. Cancer Genet Cytogenet 1985; 17: 189-255.
47. Dewald GW, Davies MP, Pierre RV, O'Fallon JR, Hoagland HC. Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. Blood 1985; 66: 189-197.
48. Teerenhovi L. Specificity of haematological indicators for '5q-syndrome' in patients with myelodysplastic syndromes. Eur J Haematol 1987; 39: 326-330.
49. Thiede T, Engquist L, Billström R. Application of megakaryocyte morphology in diagnosing 5q-syndrome. Eur J Haematol 1988; 41: 434-437.
50. Le Beau MM, Lemons RS, Espinosa R III, Larson RA, Arai N, Rowley JD. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 1989; 73: 647-650.